Do price subsidies on artemisinin combination therapy for malaria increase household use? Evidence from a repeated cross-sectional study in remote regions of Tanzania
about
Has Tanzania embraced the green leaf? Results from outlet and household surveys before and after implementation of the Affordable Medicines Facility-malariaCluster randomized trial of text message reminders to retail staff in tanzanian drug shops dispensing artemether-lumefantrine: effect on dispenser knowledge and patient adherenceDiffusion of subsidized ACTs in accredited drug shops in Tanzania: determinants of stocking and characteristics of early and late adoptersDeterminants of malaria diagnostic uptake in the retail sector: qualitative analysis from focus groups in Uganda.Are Tanzanian patients attending public facilities or private retailers more likely to adhere to artemisinin-based combination therapy?Disparities between malaria infection and treatment rates: Evidence from a cross-sectional analysis of households in Uganda.Population coverage of artemisinin-based combination treatment in children younger than 5 years with fever and Plasmodium falciparum infection in Africa, 2003-2015: a modelling study using data from national surveys.The epidemiology of residual Plasmodium falciparum malaria transmission and infection burden in an African city with high coverage of multiple vector control measures.Towards subsidized malaria rapid diagnostic tests. Lessons learned from programmes to subsidise artemisinin-based combination therapies in the private sector: a reviewChanges in the availability and affordability of subsidised artemisinin combination therapy in the private drug retail sector in rural Ghana: before and after the introduction of the AMFm subsidy.Introducing rapid diagnostic tests for malaria to drug shops in Uganda: a cluster-randomized controlled trial.
P2860
Q28538653-7B6A0B31-7FDB-4C81-AB7B-017CCB328631Q34281687-08DB9BFB-2CFC-4511-A654-81C0D679C29EQ35071309-124079F6-587F-46FF-8AAA-AFA6033A1397Q35115434-28F3ECB0-0C3D-4335-9A14-3ED061EB8D66Q35122087-C45D8499-A2FC-4ABA-96CD-05EC8E2723D3Q36291546-13D533FD-10EC-44C0-9D27-9BDAEC6A63D0Q36306811-4A310258-1C13-4B8B-9ED6-7F583AE641F5Q36929594-A7C32141-F7F1-42C0-BA6D-B346009C8FF1Q37159612-23F57600-3829-4737-B7DF-FBE374B5EC28Q38876430-1BDB4980-E7D8-4893-B9E2-0F56396010EEQ49451616-19579E72-3FCD-41C1-857C-121506AA1882
P2860
Do price subsidies on artemisinin combination therapy for malaria increase household use? Evidence from a repeated cross-sectional study in remote regions of Tanzania
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Do price subsidies on artemisi ...... in remote regions of Tanzania
@ast
Do price subsidies on artemisi ...... in remote regions of Tanzania
@en
Do price subsidies on artemisi ...... in remote regions of Tanzania
@nl
type
label
Do price subsidies on artemisi ...... in remote regions of Tanzania
@ast
Do price subsidies on artemisi ...... in remote regions of Tanzania
@en
Do price subsidies on artemisi ...... in remote regions of Tanzania
@nl
prefLabel
Do price subsidies on artemisi ...... in remote regions of Tanzania
@ast
Do price subsidies on artemisi ...... in remote regions of Tanzania
@en
Do price subsidies on artemisi ...... in remote regions of Tanzania
@nl
P2093
P2860
P921
P3181
P1433
P1476
Do price subsidies on artemisi ...... in remote regions of Tanzania
@en
P2093
Corrina Moucheraud
Jean Arkedis
Jessica L Cohen
Julius Massaga
Oliver Sabot
Peter S Larson
Prashant Yadav
Sarah Alphs
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0070713
P407
P577
2013-01-01T00:00:00Z